HomeIBT-B • STO
add
Infant Bacterial Therapeutics AB
Previous close
kr 53.50
Day range
kr 52.50 - kr 54.40
Year range
kr 21.70 - kr 135.00
Market cap
692.56M SEK
Avg Volume
24.99K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
(SEK) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | -1.00K | — |
Operating expense | 37.44M | -17.98% |
Net income | -33.76M | 17.43% |
Net profit margin | 3.38M | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(SEK) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 223.39M | -32.11% |
Total assets | 239.57M | -31.81% |
Total liabilities | 69.30M | 50.07% |
Total equity | 170.26M | — |
Shares outstanding | 13.47M | — |
Price to book | 4.23 | — |
Return on assets | -39.10% | — |
Return on capital | -50.02% | — |
Cash Flow
Net change in cash
(SEK) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -33.76M | 17.43% |
Cash from operations | -8.14M | 71.68% |
Cash from investing | — | — |
Cash from financing | 0.00 | — |
Net change in cash | -2.81M | 92.64% |
Free cash flow | 7.55M | 129.29% |
About
Founded
2011
Website
Employees
8